Skip to content

Core Scientific, Inc. CORZ Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

Applied Digital logo
Applied DigitalAPLD

Other financials

Income statement

See full
Revenue$115.2M+44.9%
Gross profit$30.1M+267%
Operating income-$310.4M-560%
Net income-$347.2M-160%
EPS (diluted)-$1.06-185%

Balance sheet

See full
Cash & equivalents$1.1B+64.0%
Total debt$2.2B+82.8%
Total equity-$1.3B-323%
Total assets$3.1B+88.9%

Cash flow

See full
Operating cash flow$249.9M+655%
CapEx$389.2M+363%
Free cash flow-$139.3M-8.0%

Valuation

See full
Market cap$9.27B+121%
Enterprise value$10.28B+119%
P/S26.1×+15.9×

Profitability

See full
Gross margin16.9%+4.3pp
Operating margin-144.7%-478pp
Net margin-238.9%-1.8pp
FCF margin-130%-246pp

Returns & leverage

See full
Return on equity-242.4%
Debt / equity2.2×
Current ratio0.5×-3.7×

Where this comes from

Reported directly by Core Scientific, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: Core Scientific, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Scientific, Inc.'s proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Scientific, Inc.'s proceeds from warrant exercises?
Core Scientific, Inc. (CORZ) reported proceeds from warrant exercises of $81K in Q1 2026.
How has Core Scientific, Inc.'s proceeds from warrant exercises changed year-over-year?
Core Scientific, Inc.'s proceeds from warrant exercises decreased by 69.5% year-over-year, from $266K to $81K.
What does proceeds from warrant exercises mean?
Cash received when investors exercise their stock warrants.
How do you interpret proceeds from warrant exercises?
Higher proceeds indicate that warrant holders are converting their rights into equity, providing cash to the company.
How does proceeds from warrant exercises compare across companies?
Common for companies with complex capital structures involving warrants or convertible securities.